• Assay Selection Tool

BellBrook Labs

  • Products
    • Transcreener® HTS Assays
      • Transcreener® ADP² Kinase Assay
      • Transcreener® ADO CD73 Assay
      • Transcreener® AMP²/GMP² Phosphodiesterase Assay
      • Transcreener® cGAMP cGAS Assay
      • Transcreener® EPIGEN SAH Methyltransferase Assay
      • Transcreener® GDP GTPase Assay Kits
      • Transcreener® UDP² Glycosyltransferase Assay
      • Transcreener® 2-5A OAS Assay
    • AptaFluor® HTS Assays
      • AptaFluor® SAH Methyltransferase Assay
    • HTS Assays by Target Family
      • Kinase Assay Kits
      • ATPase Assay Kits
      • Glycosyltransferase Assay Kits
      • GTPase Assay Kits
        • GAP Assay Kits
        • GEF Assay Kits
      • Ligase and Synthetase Assay Kits
      • Methyltransferase Assay Kits
      • Phosphodiesterase Assay Kits
    • HTS Assays by Target
      • Adenosine Kinase Assay Kits
      • AMPK Assay Kits
      • CD39 Assay Kits
      • CD73 Assay Kits
      • cGAS Assay Kits
      • DDX3 Assay Kits
      • ENPP1 Assay Kits
      • EZH2 Assay Kits
      • IKK-beta Assay Kits
      • IRAK4 Assay Kits
      • JAK1 Assay Kits
      • JAK3 Assay Kits
      • NSP13 Assay Kits
      • NUDT5 Assay Kits
      • OAS Assay Kits
      • PKR Assay Kits
      • TBK1 Assay Kits
    • Recombinant Enzymes
      • Human cGAS Enzyme
      • Mouse cGAS Enzyme
      • Human DDX3 Enzyme
      • Human OAS1 Enzyme
    • Assay Plates
    • Ordering Information
  • Services
    • Assay Development Services
    • Lead Discovery Services
    • CD38 Assay Services
    • GTPase Profiling Services
  • Innate Immunity
    • ADK Activity Assays
    • AMPK Activity Assays
    • cGAS Activity Assays
    • CD73 Activity Assays
    • CD38 Activity Assay Services
    • CD39 Activity Assays
    • DDX3 Activity Assays
    • ENPP1 Activity Assays
    • IKK-beta Activity Assays
    • IRAK4 Activity Assays
    • JAK1 Activity Assays
    • JAK3 Activity Assays
    • NSP13 Activity Assays
    • OAS1 Activity Assays
    • PKR Activity Assays
    • TBK1 Activity Assays
  • Resources
    • Technical Manuals
    • Transcreener® Assays – Instrument Compatibility
    • Application Notes
    • Posters and Presentations
    • Publications
    • Transcreener® FAQ’s
    • Guides
      • Residence Time Guide
      • Hit Prioritization Guide
      • Kinases in Innate Immunity
  • Company
    • President’s Message
    • International Distributors
    • Careers
    • Downloads
    • Contact Us
  • Blog
  • MY CART
    No products in cart.

How a Methyltransferase Activity Assay Could Help Identify Novel Breast Cancer Treatments

by Bellbrook Labs / Monday, 22 April 2019 / Published in HTS Assays, Products
Pink Stethascope DOT1L Breast Cancer Target 420 X 280

As estrogen receptor (ER) positive breast cancer (BC) becomes resistant to antiestrogen therapy, novel ways to control the disease are and continue to be developed. There are different types of breast cancer, and the most effective treatment depends on knowing this difference.  For example, if the type is estrogen receptor positive (ER) meaning cells are relying on this protein receptor to grow, then a therapy blocking the receptor is imperative.1 What happens when these types of cancer cells become resistant to the so-called antiestrogen therapies, which often occurs? Even though there is a myriad of potential causes for resistance, the bottom line is that it must be stopped or at the very least, controlled in order for patients to remain living cancer free. A recent study found a histone methyltransferase called DOT1L (disruptor of telomeric silencing-1-like) that when inhibited, silences the ERα gene making it a potential target for treating antiestrogen resistant ER-positive BCs.²

Histone methyltransferases (HMT) are enzymes that assist in the transferring of methyl groups to lysine and arginine residues of histone proteins. Histone methylation plays an essential role in a variety of biological processes such as gene expression, cell lineage development, and mitosis. Nassa et al. found that both the H3K79 methyltransferase, DOT1L, and the ERα protein associate together with chromatin.3 In addition, after further investigation of the chromatin-bound ERα-DOT1L complex, they observed other molecules involved in the progression of ER-positive BCs via cell cycle progression, cell survival, and transcription.  Moreover, they found that when DOT1L was inhibited, a decreased progression in ER-positive BCs was detected.

Being able to measure HMTs activity is necessary especially in research involving gene regulation. DOT1L, as well as other HMTs, can be calculated using a methyltransferase activity assay.

How Can a Methyltransferase Activity Assay Help?

While most methyltransferase activity assays detect the invariant product of HMT reactions, S-adenosylhomocysteine (SAH) indirectly or by the use of coupled enzymes, the AptaFluor SAH Methyltransferase Assay affords direct detection. Not only is this universal approach capable of detecting a range of HMT activity including DOT1L, it also allows for more sensitive binding to SAH making the assay remarkable for high-throughput screening (HTS).4   Whether researching gene regulation in breast cancer or exploring DNA repair mechanisms, the AptaFluor SAH Methyltransferase Assay can assist in evaluating the HMT of interest, finding new inhibitors faster, thus accelerating drug discovery.

DOT1L Titration Using Methyltransferase Activity AssayDOT1L Titration Under Initial Velocity ConditionsInhibitor Potency with DOT1L

A. Dot1L was titrated in the presence of 200 nM SAM and 10 ng/µL of mono/di nucleosomes to determine an optimal EC80 concentration of 6 ng/µL. Reactions were incubated at 30C for two hours. B. TR-FRET values were converted to SAH production to assess reaction progress. C. Dose-response curves with two known inhibitors of Dot1L, EPZ004777 and EPZ5676 show an IC50 value of 1.7 nM and 1.4 nM respectively.

References

  1. Cancer B, Breast Cancer Hormone Receptor Status 2019:1-4. https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-hormone-receptor-status.html
  2. Frogne T, Jepsen JS, Larsen SS, Fog CK, Brockdorff BL, Lykkesfeldt AE. Antiestrogen-resistant human breast cancer cells require activated Protein Kinase B / Akt for growth. 2005:599-614. https://europepmc.org/abstract/med/16172194
  3. Nassa G, Salvati A, Tarallo R, et al. Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells. 2019;(February):1-15. https://advances.sciencemag.org/content/5/2/eaav5590
  4. AptaFluor SAH: A Homogenous, Universal Methyltransferase Assay Based on a Microbial Riboswitch Meera Kumar and Robert G . Lowery. :2017. https://www.bellbrooklabs.com/wp-content/uploads/2018/01/AptaFluor-SAH-A-Homogenous-Universal-Methyltransferase-Assay-Based-on-a-Microbial-Riboswitch-DOT-2017.pdf
Tagged under: AptaFluor SAH Methyltransferase Assay, methyltransferase

What you can read next

Another Tool for the HTS Toolbox: Two Additional Plate Readers Certified for Transcreener Assays
Small GTPase Modulation
Small GTPase Modulation: GDP Assays to Accelerate Discovery
FUT7 Fucosyltransferase Assays and Chronic Inflammation
FUT7, Inflammation, and Fucosyltransferase Assays

Categories

  • Company
  • Emerging Targets
  • Epigenetics
  • HTS Assays
  • Innate Immunity
  • Neurodegenerative Diseases
  • News
  • Products
  • Resources
  • Success Stories
  • Uncategorized

Recent Posts

  • Info book on cancer and RAFK1's relation

    RAF1 & Immunity: A Future Model For Cancer Research?

    RAF1, also known as c-Raf, is a member of the R...
  • OAS1 The Cost of Host Defense

    OAS1: The Cost of Host Defense

    OAS1 (Oligoadenylate synthetase 1) is induced b...
  • Scientist Studying DDX41

    DDX41 as a Sensor, Suppressor, and Modulator

    DDX41 [DEAD (Asp-Glu-Ala-Asp) Box Polypeptide 4...
  • Scientist Studying ALKPK1

    The Role of ALPK1 in Health and Disease

    ALPK1 (Alpha Kinase 1) is an atypical serine/th...
  • DHX36 RNA Helicase Unwinds G4 RNA Structures

    Resolving the Many Roles of DHX36

    While most researchers are familiar with canoni...

Archives

BellBrook Labs
5500 Nobel Drive, Suite 230
Madison, Wisconsin 53711 USA
(608) 443-2400

info@bellbrooklabs.com

 Copyright © 2022 BellBrook Labs | All Rights Reserved | Privacy Policy | Terms of Use | FCOI | Sitemap

TOP